No Data
CINC, Good Patch and others.
The share buyback by CINCF has a maximum of 0.52 million shares (15.42% of the total shares issued) and will be purchased on the 19th through ToSTNeT-3. DWTI has completed the administration of the treatment for corneal endothelial degeneration, "K-321", in the Global Phase III clinical trial. KAIOM has signed a business partnership agreement with SRD, which handles clinical development and regulatory support for Pharmaceuticals and Medical Devices.
<Individual Stock Trends> Tekken Construction, Stem Inc, Kaiom, Kyowa Industrial, Electrical Utilities HD = 18th afternoon session.
Tekkou Construction <1815.T> - A total of 695,000 shares will be retired as of March 26, representing 4.44% of the issued shares before retirement. Stem Inc <3804.T> - The consolidated financial results for the first quarter of the fiscal year ending October 2025 (November 2024 - January 2025) landed with significant profit increases. Kaiom <4583.T> - A business partnership contract has been concluded with SRD (Chuo-ku, Tokyo) that supports the development of Pharmaceuticals. Kyowa Industry <5971.T> - Cumulative results for the third quarter of the fiscal year ending April 2025 (May 2024 - January 2025).
Chiome Bioscience Updates Financial Results for FY 2024
Chiome Bioscience: (Correction/Numerical Data Correction) Notice Concerning Partial Corrections to the “Financial Results for the Fiscal Year Ending December 2024/12 [Japanese GAAP] (Unconsolidated)”
Chiome Bioscience and OmniAb Collaborate on Antibody Research
Sony Group Corp has revised its forecast upwards for March 25, with operating profit of 1 trillion 335 billion yen, up from 1 trillion 310 billion yen.
Sony Group Corp (6758) announced a revision of its Financial Estimates for the fiscal year ending March 2025. Revenue has been revised upwards from 12 trillion 710 billion yen to 13 trillion 200 billion yen, and operating profit from 1 trillion 310 billion yen to 1 trillion 335 billion yen. Entertainment-related segments such as Gaming and music are performing steadily. Additionally, it was announced that a share buyback program with a cap of 50 billion yen has been established, allowing the purchase of up to 30 million shares (0.5% of the total issued shares excluding treasury shares) in the market. 【Positive evaluation】<675